The emerging class of GLP-1 receptor and GIP dual medications, such as tirzepatide, semaglutide, and the newly introduced retatrutide, offer promising improvements in the treatment . Despite all three https://motscpeptide165932.full-design.com/tirzepatide-one-detailed-examination-86457209